Tony Michael Argenbright
Examiner (ID: 16324)
Most Active Art Unit | 3402 |
Art Unit(s) | 3402, 3747 |
Total Applications | 2731 |
Issued Applications | 2589 |
Pending Applications | 40 |
Abandoned Applications | 102 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8683961
[patent_doc_number] => 20130052245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'COSMETIC AND DERMATOLOGICAL FORMULATIONS OF MNTF PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/659782
[patent_app_country] => US
[patent_app_date] => 2012-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13416
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13659782
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/659782 | COSMETIC AND DERMATOLOGICAL FORMULATIONS OF MNTF PEPTIDES | Oct 23, 2012 | Abandoned |
Array
(
[id] => 8744902
[patent_doc_number] => 20130084618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-04
[patent_title] => 'PHENOLIC BINDING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/622978
[patent_app_country] => US
[patent_app_date] => 2012-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11125
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13622978
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/622978 | PHENOLIC BINDING PEPTIDES | Sep 18, 2012 | Abandoned |
Array
(
[id] => 8814188
[patent_doc_number] => 20130115233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'METHODS FOR DESIGNING AND SYNTHESIZING DIRECTED SEQUENCE POLYMER COMPOSITIONS VIA THE DIRECTED EXPANSION OF EPITOPE PERMEABILITY'
[patent_app_type] => utility
[patent_app_number] => 13/618273
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22667
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13618273
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/618273 | METHODS FOR DESIGNING AND SYNTHESIZING DIRECTED SEQUENCE POLYMER COMPOSITIONS VIA THE DIRECTED EXPANSION OF EPITOPE PERMEABILITY | Sep 13, 2012 | Abandoned |
Array
(
[id] => 11907090
[patent_doc_number] => 09775886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Human placental collagen compositions, and methods of making and using the same'
[patent_app_type] => utility
[patent_app_number] => 13/610375
[patent_app_country] => US
[patent_app_date] => 2012-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 33152
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13610375
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/610375 | Human placental collagen compositions, and methods of making and using the same | Sep 10, 2012 | Issued |
Array
(
[id] => 8697763
[patent_doc_number] => 20130059772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'Use of Repeat Sequence Protein Polymers in Personal Care Compositions'
[patent_app_type] => utility
[patent_app_number] => 13/594572
[patent_app_country] => US
[patent_app_date] => 2012-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 36175
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13594572
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/594572 | Use of Repeat Sequence Protein Polymers in Personal Care Compositions | Aug 23, 2012 | Abandoned |
Array
(
[id] => 8522293
[patent_doc_number] => 20120321701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'ANG-(1-7) RECEPTOR AGONIST'
[patent_app_type] => utility
[patent_app_number] => 13/590894
[patent_app_country] => US
[patent_app_date] => 2012-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3836
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13590894
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/590894 | Ang-(1-7) receptor agonist | Aug 20, 2012 | Issued |
Array
(
[id] => 10920383
[patent_doc_number] => 20140323402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'Protein Carrier-Linked Prodrugs'
[patent_app_type] => utility
[patent_app_number] => 14/238088
[patent_app_country] => US
[patent_app_date] => 2012-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41025
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14238088
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/238088 | Protein Carrier-Linked Prodrugs | Aug 9, 2012 | Abandoned |
Array
(
[id] => 9686489
[patent_doc_number] => 20140243254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'Polymeric Hyperbranched Carrier-Linked Prodrugs'
[patent_app_type] => utility
[patent_app_number] => 14/237833
[patent_app_country] => US
[patent_app_date] => 2012-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37774
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237833
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/237833 | Polymeric Hyperbranched Carrier-Linked Prodrugs | Aug 9, 2012 | Abandoned |
Array
(
[id] => 9570031
[patent_doc_number] => 20140187744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'Bilirubin Excretion Enhancer'
[patent_app_type] => utility
[patent_app_number] => 14/237694
[patent_app_country] => US
[patent_app_date] => 2012-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4249
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237694
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/237694 | Bilirubin Excretion Enhancer | Aug 8, 2012 | Abandoned |
Array
(
[id] => 11296767
[patent_doc_number] => 09504759
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-29
[patent_title] => 'Surface modified proteinaceous spherical particles and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/237890
[patent_app_country] => US
[patent_app_date] => 2012-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8822
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237890
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/237890 | Surface modified proteinaceous spherical particles and uses thereof | Aug 7, 2012 | Issued |
Array
(
[id] => 9538556
[patent_doc_number] => 20140163203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'PROCESS FOR PREPARING EPTIFIBATIDE'
[patent_app_type] => utility
[patent_app_number] => 14/235349
[patent_app_country] => US
[patent_app_date] => 2012-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15266
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14235349
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/235349 | Process for preparing eptifibatide | Jul 25, 2012 | Issued |
Array
(
[id] => 10063920
[patent_doc_number] => 09102753
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-11
[patent_title] => 'Anti-inflammatory pharmaceutical products'
[patent_app_type] => utility
[patent_app_number] => 13/524381
[patent_app_country] => US
[patent_app_date] => 2012-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 11154
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13524381
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/524381 | Anti-inflammatory pharmaceutical products | Jun 14, 2012 | Issued |
Array
(
[id] => 9464145
[patent_doc_number] => 20140128572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'Process For Extraction Of Peptides And Its Application In Liquid Phase Peptide Synthesis'
[patent_app_type] => utility
[patent_app_number] => 14/125804
[patent_app_country] => US
[patent_app_date] => 2012-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22640
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125804
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/125804 | Process For Extraction Of Peptides And Its Application In Liquid Phase Peptide Synthesis | Jun 13, 2012 | Abandoned |
Array
(
[id] => 9635650
[patent_doc_number] => 20140213759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-31
[patent_title] => 'Process For Extraction Of Peptides And Its Application In Liquid Phase Peptide Synthesis'
[patent_app_type] => utility
[patent_app_number] => 14/125733
[patent_app_country] => US
[patent_app_date] => 2012-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 27308
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125733
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/125733 | Process For Extraction Of Peptides And Its Application In Liquid Phase Peptide Synthesis | Jun 13, 2012 | Abandoned |
Array
(
[id] => 9657545
[patent_doc_number] => 20140228550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'Process for Obtaining Proteins from a Native Substance Mixture'
[patent_app_type] => utility
[patent_app_number] => 14/124561
[patent_app_country] => US
[patent_app_date] => 2012-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2659
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124561
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/124561 | Process for Obtaining Proteins from a Native Substance Mixture | Jun 5, 2012 | Abandoned |
Array
(
[id] => 8611901
[patent_doc_number] => 20130017213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'PEPTIDE ANALOGUES'
[patent_app_type] => utility
[patent_app_number] => 13/481741
[patent_app_country] => US
[patent_app_date] => 2012-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 42050
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13481741
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/481741 | Peptide analogues | May 24, 2012 | Issued |
Array
(
[id] => 8955918
[patent_doc_number] => 08501691
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-06
[patent_title] => 'Methods for treatment of headaches by administration of oxytocin'
[patent_app_type] => utility
[patent_app_number] => 13/480291
[patent_app_country] => US
[patent_app_date] => 2012-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 17265
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13480291
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/480291 | Methods for treatment of headaches by administration of oxytocin | May 23, 2012 | Issued |
Array
(
[id] => 8721230
[patent_doc_number] => 20130072447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'ENHANCED ORAL TRANSCOMPARTMENTAL DELIVERY OF THERAPEUTIC OR DIAGANOSTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/471083
[patent_app_country] => US
[patent_app_date] => 2012-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 28894
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13471083
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/471083 | ENHANCED ORAL TRANSCOMPARTMENTAL DELIVERY OF THERAPEUTIC OR DIAGANOSTIC AGENTS | May 13, 2012 | Abandoned |
Array
(
[id] => 10850501
[patent_doc_number] => 08877180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-04
[patent_title] => 'Human placental collagen compositions, and methods of making and using the same'
[patent_app_type] => utility
[patent_app_number] => 13/467736
[patent_app_country] => US
[patent_app_date] => 2012-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 33145
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13467736
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/467736 | Human placental collagen compositions, and methods of making and using the same | May 8, 2012 | Issued |
Array
(
[id] => 8618173
[patent_doc_number] => 20130023485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-24
[patent_title] => 'PARENTERAL FORMULATIONS OF PEPTIDES FOR THE TREATMENT OF SYSTEMATIC LUPUS ERYTHEMATOSUS'
[patent_app_type] => utility
[patent_app_number] => 13/453979
[patent_app_country] => US
[patent_app_date] => 2012-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 26216
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13453979
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/453979 | PARENTERAL FORMULATIONS OF PEPTIDES FOR THE TREATMENT OF SYSTEMATIC LUPUS ERYTHEMATOSUS | Apr 22, 2012 | Abandoned |